Bausch Health Companies Inc. Common Stock (BHC)

Stock · NYSE · Health Care

$6.32as of 8/28/2026

Price chart

Insider transactionsShow all transaction typesRevenue Growth

No technical signal is currently active for this symbol.

Support level

$5.32

Industry

Biotechnology: Pharmaceutical Preparations

Chosen by industry and closest market cap.

BHC
Bausch Health Companies Inc. Common Stock
$6.32
▲ 0.32%
Market cap $2.21BP/E —
URGN
UroGen Pharma Ltd. Ordinary Shares
$43.61
▼ 4.15%
Market cap $2.22BP/E —
$15.86$50.81
MLYS
Mineralys Therapeutics Inc. Common Stock
$25.59
▼ 1.61%
Market cap $2.23BP/E —
$14.94$47.65
SLS
SELLAS Life Sciences Group Inc. Common Stock
$13.17
▼ 13.45%
Market cap $2.18BP/E —
BHVN
Biohaven Ltd. Common Shares
$15.42
▼ 4.37%
Market cap $2.17BP/E —
$7.48$18.57
NUVB
Nuvation Bio Inc. Class A Common Stock
$6.67
▼ 4.65%
Market cap $2.13BP/E —
$2.87$9.75
VERA
Vera Therapeutics Inc. Class A Common Stock
$34.19
▼ 1.18%
Market cap $2.30BP/E —
$21.2$56.05

Symbol	Market cap	P/E ratio	Price	1D	52-week range
BHC Bausch Health Companies Inc. Common Stock	$2.21B	—	$6.32	▲ 0.32%
URGN UroGen Pharma Ltd. Ordinary Shares	$2.22B	—	$43.61	▼ 4.15%	$15.86$50.81
MLYS Mineralys Therapeutics Inc. Common Stock	$2.23B	—	$25.59	▼ 1.61%	$14.94$47.65
SLS SELLAS Life Sciences Group Inc. Common Stock	$2.18B	—	$13.17	▼ 13.45%
BHVN Biohaven Ltd. Common Shares	$2.17B	—	$15.42	▼ 4.37%	$7.48$18.57
NUVB Nuvation Bio Inc. Class A Common Stock	$2.13B	—	$6.67	▼ 4.65%	$2.87$9.75
VERA Vera Therapeutics Inc. Class A Common Stock	$2.30B	—	$34.19	▼ 1.18%	$21.2$56.05

P/E shows — for peers not currently carrying a live signal of their own.

March 31, 2026

Top holders this quarter

See the full, filterable feed with live charts on the MarketWall dashboard.